DrugPatentWatch Database Preview
Investigational Drug Information for Betadex
Email this page to a colleague
What is the development status for investigational drug Betadex?
Betadex is an investigational drug.
There have been 11 clinical trials for Betadex.
The most recent clinical trial was a Phase 3 trial, which was initiated on October 1st 2016.
The most common disease conditions in clinical trials are Niemann-Pick Diseases, Niemann-Pick Disease, Type C, and Niemann-Pick Disease, Type A. The leading clinical trial sponsors are Bayer, Mandos LLC, and Vtesse, LLC, a Mallinckrodt Pharmaceuticals Company.
There are five hundred and eighty-two US patents protecting this investigational drug and twelve international patents.
Summary for Betadex
| US Patents | 582 |
| International Patents | 12,628 |
| US Patent Applications | 7,900 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 125 |
| Clinical Trial Progress | Phase 3 (2016-10-01) |
| Vendors | 39 |
Recent Clinical Trials for Betadex
| Title | Sponsor | Phase |
|---|---|---|
| Study in Women on the Effect of JNJ-64530440 on Oral Contraceptive and Midazolam, and the Effect of a High-fat Meal on JNJ-64530440 | Janssen Research & Development, LLC | Phase 1 |
| Niemann-Pick Type C Treatment With Adrabetadex for Symptoms of Brain and Nervous System | Mandos LLC | Phase 3 |
| Niemann-Pick Type C Treatment With Adrabetadex for Symptoms of Brain and Nervous System | Vtesse, Inc., a Mallinckrodt Pharmaceuticals Company | Phase 3 |
Clinical Trial Summary for Betadex
Top disease conditions for Betadex
Top clinical trial sponsors for Betadex
US Patents for Betadex
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Betadex | ⤷ Try it Free | Antifungal compound process | Mycovia Pharmaceuticals, Inc. (Durham, NC) U.S. Department of Health and Human Services (Washington, DC) | ⤷ Try it Free |
| Betadex | ⤷ Try it Free | Pharmaceutical composition for preventing or treating skin cancer comprising Panax spp. plant extract and method of preventing or treating skin cancer in a subject using the same | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (Seoul, KR) | ⤷ Try it Free |
| Betadex | ⤷ Try it Free | Low, immune enhancing, dose mtor inhibitors and uses thereof | Novartis AG (Basel, CH) | ⤷ Try it Free |
| Betadex | ⤷ Try it Free | Neprilysin inhibitors | THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA) | ⤷ Try it Free |
| Betadex | ⤷ Try it Free | Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer | Capella Therapeutics, Inc. (San Diego, CA) | ⤷ Try it Free |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Betadex
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Betadex | Australia | AU2015231234 | 2034-03-19 | ⤷ Try it Free |
| Betadex | Canada | CA2942972 | 2034-03-19 | ⤷ Try it Free |
| Betadex | European Patent Office | EP3119755 | 2034-03-19 | ⤷ Try it Free |
| Betadex | Japan | JP2017509646 | 2034-03-19 | ⤷ Try it Free |
| Betadex | World Intellectual Property Organization (WIPO) | WO2015143180 | 2034-03-19 | ⤷ Try it Free |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
